We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPT icon
1751
Sprout Social
SPT
$617M
$2.55M ﹤0.01%
71,399
+1,911
+3% +$76.9K
JBSS icon
1752
John B. Sanfilippo & Son
JBSS
$985M
$2.55M ﹤0.01%
26,208
+38
+0.1% +$3.8K
HCSG icon
1753
Healthcare Services Group
HCSG
$1.54B
$2.55M ﹤0.01%
240,592
+9,590
+4% +$106K
DRS icon
1754
Leonardo DRS
DRS
$12B
$2.54M ﹤0.01%
99,709
+10,492
+12% +$240K
SHEL icon
1755
Shell
SHEL
$244B
$2.53M ﹤0.01%
35,107
+3,143
+10% +$225K
RWT
1756
Redwood Trust
RWT
$595M
$2.53M ﹤0.01%
390,185
+6,242
+2% +$38.8K
NVAX icon
1757
Novavax
NVAX
$1.31B
$2.53M ﹤0.01%
199,909
+56,324
+39% +$567K
NMRK icon
1758
Newmark Group
NMRK
$2.65B
$2.53M ﹤0.01%
247,351
+4,888
+2% +$49.8K
AMSF icon
1759
AMERISAFE
AMSF
$543M
$2.53M ﹤0.01%
57,567
-9,444
-14% -$433K
RCUS icon
1760
Arcus Biosciences
RCUS
$3.62B
$2.53M ﹤0.01%
165,835
-6,838
-4% -$110K
AGNT
1761
AGNT Inc
AGNT
$729M
$2.52M ﹤0.01%
223,543
+9,979
+5% +$109K
AKRO
1762
DELISTED
Akero Therapeutics
AKRO
$2.52M ﹤0.01%
107,338
+24,940
+30% +$533K
LBTYA icon
1763
Liberty Global Class A
LBTYA
$3.62B
$2.51M ﹤0.01%
144,156
+137,817
+2,174% +$2.33M
SBSI icon
1764
Southside Bancshares
SBSI
$975M
$2.51M ﹤0.01%
90,893
-1,072
-1% -$29.1K
KNTK icon
1765
Kinetik
KNTK
$3.6B
$2.51M ﹤0.01%
60,529
+9,044
+18% +$359K
PRLB icon
1766
Protolabs
PRLB
$2.12B
$2.51M ﹤0.01%
81,102
-3,908
-5% -$124K
ARDX icon
1767
Ardelyx
ARDX
$988M
$2.5M ﹤0.01%
337,967
+393
+0.1% +$2.76K
TCBK icon
1768
TriCo Bancshares
TCBK
$1.85B
$2.5M ﹤0.01%
63,125
+1,109
+2% +$40.1K
ASC icon
1769
Ardmore Shipping
ASC
$684M
$2.5M ﹤0.01%
110,808
+2,744
+3% +$54.1K
PKX icon
1770
POSCO
PKX
$17.5B
$2.49M ﹤0.01%
37,804
-10,315
-21% -$731K
HLIO icon
1771
Helios Technologies
HLIO
$2.74B
$2.48M ﹤0.01%
52,041
+4,026
+8% +$193K
RELY icon
1772
Remitly
RELY
$5.14B
$2.48M ﹤0.01%
204,708
+19,884
+11% +$308K
SHEN icon
1773
Shenandoah Telecom
SHEN
$749M
$2.46M ﹤0.01%
150,439
-1,108
-0.7% -$17.8K
SNDX icon
1774
Syndax Pharmaceuticals
SNDX
$1.79B
$2.45M ﹤0.01%
119,285
+10,291
+9% +$215K
PRAA icon
1775
PRA Group
PRAA
$773M
$2.45M ﹤0.01%
124,526
-1,787
-1% -$41.1K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.